Herpes Simplex Virus News and Research

RSS
Female sex hormone estradiol may protect women against sexually transmitted viral infections

Female sex hormone estradiol may protect women against sexually transmitted viral infections

LJI study could provide important target for autoimmune disease interventions

LJI study could provide important target for autoimmune disease interventions

ZOTEN nanoparticles can help develop natural immunity against genital herpes

ZOTEN nanoparticles can help develop natural immunity against genital herpes

Hormonal contraception may increase susceptibility of women to genital infection

Hormonal contraception may increase susceptibility of women to genital infection

Scientists reveal mechanism involved in regulation of lymphangiogenesis

Scientists reveal mechanism involved in regulation of lymphangiogenesis

Innovative HIV vaccine candidate generates protection against repeated AIDS virus exposures

Innovative HIV vaccine candidate generates protection against repeated AIDS virus exposures

Forensic scientists find that HSV-1 strains could be useful for tracing a person's history

Forensic scientists find that HSV-1 strains could be useful for tracing a person's history

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

High school wrestlers have highest number of skin infections

High school wrestlers have highest number of skin infections

Study shows several Envigo rat models susceptible to genital HSV-2 infection

Study shows several Envigo rat models susceptible to genital HSV-2 infection

Profectus begins Phase 1 clinical study of VesiculoVax-vectored Ebola virus vaccine

Profectus begins Phase 1 clinical study of VesiculoVax-vectored Ebola virus vaccine

Rutgers Cancer Institute scientist leads phase III trial of FDA-approved viral melanoma therapy

Rutgers Cancer Institute scientist leads phase III trial of FDA-approved viral melanoma therapy

Over 3.7 billion people under 50 have genital HSV-1 infection, shows WHO report

Over 3.7 billion people under 50 have genital HSV-1 infection, shows WHO report

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

Luminex receives rapid clearance from FDA for ARIES System and ARIES HSV 1&2 Assay

Luminex receives rapid clearance from FDA for ARIES System and ARIES HSV 1&2 Assay

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Blavatnik Biomedical Accelerator funds advanced biomedical research projects

Blavatnik Biomedical Accelerator funds advanced biomedical research projects

Researchers capture images of immune cell interactions rallying to destroy herpes simplex virus

Researchers capture images of immune cell interactions rallying to destroy herpes simplex virus

Reducing amyloid fibril levels in semen may help reduce transmission of HIV

Reducing amyloid fibril levels in semen may help reduce transmission of HIV

NanoViricides speeds up HerpeCide drug development program

NanoViricides speeds up HerpeCide drug development program

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.